Corash L, Lin L, Wiesehahn G
Department of Laboratory Medicine, University of California, San Francisco 94143.
Blood Cells. 1992;18(1):57-73; discussion 74. doi: 10.1117/12.137506.
Transmission of viral diseases through blood products remains a problem in transfusion medicine. We have developed a photochemical decontamination system (PCD) for platelet concentrates (PC) utilizing treatment with long wavelength ultraviolet radiation (UVA, 320-400 nm) and 8-methoxypsorlan (8-MOP). This system is capable of inactivating 25-30 logs/hour of bacteria E. coli or S. aureus, 6 logs/hour of bacteriophage fd, 0.9 log/hour of bacteriophage R17, and 1.1 logs/hour of feline leukemia virus (FeLV) in PC. Immediately following 6 hours of PCD treatment, platelet integrity and function of PCD-treated and control PC were equivalent. After overnight storage, PCD-treated and control PC platelet properties were equal, but there was a slight reduction in TXB-2 production of PCD-treated PC compared to controls. Following PCD treatment, PC were stored for 48 to 96 hours. Platelet counts, morphology scores, extracellular LDH levels, aggregation response, dense body (db) content, and alpha granule (alpha g) content of PCD-treated and control PC were comparable. We assessed the ability of the PCD technique to inactivate intracellular and extracellular virus, quantified the degree of DNA adduct formation in contaminating lymphocytes, and measured the inhibition of polymerase chain reaction (PCR) mediated amplification of intracellular DNA. High titers of cell-free murine cytomegalovirus added to human platelet concentrates (final concentration 10(6)) were inactivated by PCD within 30 minutes. Cat renal fibroblasts infected at high levels with feline rhinotracheitis virus (FeRTV) were seeded into PC followed by PCD treatment with inactivation of 4.8 logs of FeRTV within 10 minutes. Purified human lymphocytes were seeded into PC and treated with PCD in the presence of 3H 8-MOP. Six hours of PCD treatment resulted in the formation of 9.3 to 12.8 8-MOP adducts per 1000 base pairs (bp) of DNA. PCR amplification of a 242 bp segment at the HLA-DQ alpha locus was examined. Inhibition of PCR DNA amplification was dependent on the numbers of 8-MOP adducts formed, and no amplification was present when greater than 12 adducts per 1000 bp were formed. These studies indicate that PCD can effectively inactivate high titers of cell-associated and cell-free virus seeded into standard human PC. The efficiency of DNA adduct formation can be quantitated, and the level of 8-MOP adduct formation in lymphocytes contaminating PC is comparable to the level of adduct formation in cellular DNA reported in the absence of platelets.
通过血液制品传播病毒性疾病仍是输血医学中的一个问题。我们开发了一种用于浓缩血小板(PC)的光化学去污系统(PCD),该系统利用长波长紫外线辐射(UVA,320 - 400 nm)和8 - 甲氧基补骨脂素(8 - MOP)进行处理。该系统能够每小时灭活25 - 30个对数级的大肠杆菌或金黄色葡萄球菌、每小时6个对数级的噬菌体fd、每小时0.9个对数级的噬菌体R17以及每小时1.1个对数级的猫白血病病毒(FeLV)。在PCD处理6小时后,立即检测发现经PCD处理的PC和对照PC的血小板完整性和功能相当。过夜储存后,经PCD处理的PC和对照PC的血小板特性相同,但与对照相比,经PCD处理的PC中TXB - 2的产生略有减少。PCD处理后,PC被储存48至96小时。经PCD处理的PC和对照PC的血小板计数、形态学评分、细胞外乳酸脱氢酶水平、聚集反应、致密体(db)含量和α颗粒(αg)含量相当。我们评估了PCD技术灭活细胞内和细胞外病毒的能力,量化了污染淋巴细胞中DNA加合物形成的程度,并测量了聚合酶链反应(PCR)介导的细胞内DNA扩增抑制情况。添加到人类浓缩血小板中的高滴度无细胞鼠巨细胞病毒(最终浓度10(6))在30分钟内被PCD灭活。将被猫鼻气管炎病毒(FeRTV)高水平感染的猫肾成纤维细胞接种到PC中,随后进行PCD处理,10分钟内可灭活4.8个对数级的FeRTV。将纯化的人类淋巴细胞接种到PC中,并在3H标记的8 - MOP存在下进行PCD处理。6小时的PCD处理导致每1000个碱基对(bp)的DNA形成9.3至12.8个8 - MOP加合物。检测了HLA - DQα基因座处242 bp片段的PCR扩增情况。PCR DNA扩增的抑制取决于形成的8 - MOP加合物数量,当每1000 bp形成大于12个加合物时则无扩增。这些研究表明,PCD能够有效灭活接种到标准人类PC中的高滴度细胞相关和无细胞病毒。DNA加合物形成的效率可以定量,并且污染PC的淋巴细胞中8 - MOP加合物的形成水平与在无血小板情况下报道的细胞DNA中加合物形成水平相当。